Potent Tetracyclic Guanine Inhibitors of PDE1 and PDE5 Cyclic Guanosine Monophosphate Phosphodiesterases with Oral Antihypertensive Activity
Ho-Sam Ahn, Hongtao Zhang(Chinese Academy of Sciences), Chester Puchalski, J. T. WITKOWSKI, Brian A. McKittrick(Merck & Co., Inc., Rahway, NJ, USA (United States)), Alan Bronnenkant, Reneé Cleven, Neil Lindo, Silverman Lisa, Ana Bercovici, Michael Czarniecki(Merck & Co., Inc., Rahway, NJ, USA (United States)), Bita Mirzai, Terry L. Nechuta, Kathryn Pula, Samuel Chackalamannil, Andrew W. Stamford(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ke Ma(Johns Hopkins University), Henry Vaccaro, George Boykow, Jason Chow, Yan Xia(Stanford University), Mahua Manna, Malvina Laudicina, Hsingan Tsai, Asli Gündes, Deen Tulshian, Michael Green(University of Nevada, Las Vegas), John S. Cook, Elizabeth C. Smith, Ginny D. Ho, Ahmad Fawzi, Robert W. Watkins, Richard P. Tedesco, Bernard R. Neustadt, Carol Domalski
Cited by 81
Related Papers
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649
ErbB receptors: from oncogenes to targeted cancer therapies
|Journal of Clinical Investigation|2007|578
Advances in clinical immunotherapy for gastric cancer
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2021|435
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients
|Science Translational Medicine|2016|416